Join us at the AACR New Horizons in Cancer Research Conference

November 6-9, Shanghai, China

Don't miss our 12 posters covering a range of immuno-oncology topics including combination checkpoint inhibitor and targeted agent treatment of syngeneic cell lines and flow-based phenotyping of tumor-infiltrating immune cells in novel immuno-oncology in vivo models.

精準識別

一眼認出你的下一個臨床候選

中美冠科轉化醫學平臺能夠幫助客戶識別適合的治療方案用於合適的患者。無論是腫瘤學還是糖尿病相關疾病,擁有能夠更準確類比人類疾病的模型和群體動態的模型,是將候選化合物轉化為成功臨床候選藥物的關鍵。

開闊視野

瞭解疾病發生的機制

中美冠科敏銳的科學能力和豐富的經驗能給予您化合物的藥理學、以及有方向地去選擇哪些化合物進入臨床的深刻見解。您可以查閱我們發表的文獻來進一步瞭解我們科學經驗的深度。

洞察結果

將科學與患者相結合。

中美冠科通過回答一些關於人類生物學最挑戰的問題,協助客戶在解決腫瘤學、心血管以及代謝疾病上一些當前最緊迫的問題。

CVMD

肥胖模型

obesity-img.jpg

中美冠科生物臨床前轉化醫學技術派平臺提供自發及飼料誘導的肥胖模型(DIO),以支援新藥物進入臨床的轉化研究。

瞭解更多

腫瘤學 Oncology

腫瘤學資料庫Oncology Databases

databases-img.jpg

我們獨特的資料庫整合了我們充分研究的模型資訊,可以用於PDX模型,細胞系及同源模型的藥物研發專案。

瞭解更多

CVMD

糖尿病模型Diabetes Models

oncoexpress-img.jpg

用於抗糖尿病藥物體內藥效實驗的一型及二型糖尿病模型,包括市場上常見模型及我們獨有且具有高度轉化能力的模型。

瞭解更多

Latest from our Blog

February 22, 2018

Tumor Infiltrating Lymphocytes: Conflicting Approaches in Immuno-Oncology

Today’s new frontier in cancer treatment is in fact a very, very old frontier indeed: tumor infiltrating lymphocytes (TILs). New as they seem, TILs were first observed over 150 years ago by Rudolf Virchow, the father of modern pathology. It was a time when disease was considered to be the result of imbalanced bodily humors and his use...

Read More

February 22, 2018

Tumor Infiltrating Lymphocytes: Conflicting Approaches in Immuno-Oncology

Today’s new frontier in cancer treatment is in fact a very, very old frontier indeed: tumor...

Read More

February 20, 2018

How to Assess CAR-T Cell Therapies Preclinically

Chimeric antigen receptor (CAR)-T cell therapies are a new and novel immuno-oncology treatment...

Read More

February 16, 2018

3 Key Uses for Humanized Mouse Models

We’ve been focusing on humanized mouse models recently on our blog, from evolution of...

Read More

February 9, 2018

X Chromosome Inactivation: New Hypothesis for Lupus Gender Disparity

It’s widely accepted that lupus occurs more often in women than men, with many studies over the...

Read More

January 30, 2018

Humanized Mouse Model Head to Head: hPBMC vs hCD34+

The future of cancer treatment is often considered to be combination regimens (dual...

Read More

Upcoming Events


February 21 - 22, 2018

LabRoots Virtual Drug Discovery Event

Online, virtual Booth

Learn More


March 1, 2018

Webinar: Interrogating Syngeneic Models in Large Scale, How to Use Immunoprofiling Data to Improve your Studies

Learn More


March 5 - 9, 2018

European Seminar Series: Mouse Clinical Trials and Humanised PDX to Advance Oncology Drug Discovery

Learn More


March 13 - 14, 2018

2nd Annual Next Gen Immuno-Oncology Congress

London, UK

Learn More


March 15, 2018

Crown Bioscience Symposium: Perspectives on Oncology Drug Discovery; Immuno-Oncology and the Next Generation

Babraham Institute, Cambridge, UK

Learn More


March 19 - 21, 2018

5th Immunotherapy of Cancer Conference (iTOC5)

Berlin, Germany

Learn More


April 9-11, 2018

11th Diabetes Summit

Boston, MA

Learn More


April 14-18, 2018

AACR Annual Meeting 2018

Chicago, Illinois - Booth #3012

Learn More


April 23-25, 2018

2nd Annual NASH Summit 2018

Boston, MA

Learn More